Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
32%
OVERLAP
BY WEIGHT
20
# OF OVERLAPPING
HOLDINGS
XPH
60
HOLDINGS
34%
ALSO IN PJP
PJP
32
HOLDINGS
71%
ALSO IN XPH
SECTOR DRIFT (XPH minus PJP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
LIQUIDIA TECHNOLOGIES, INC. | 2.0% | 3.4% | 2.0% |
|
CORCEPT THERAPEUTICS INC | 1.9% | 3.8% | 1.9% |
|
LIGAND PHARMACEUTICALS-CL B | 1.8% | 3.3% | 1.8% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 1.8% | 3.6% | 1.8% |
|
BRISTOL-MYERS SQUIBB CO | 1.7% | 2.6% | 1.7% |
XPH Overweight Relative to PJP
|
CRINETICS PHARMACEUTICALS INC | 3.7% |
|
MBX BIOSCIENCES INC | 3.0% |
|
DEFINIUM THERAPEUTICS INC | 2.8% |
|
ENLIVEN THERAPEUTICS, INC. | 2.2% |
|
NUVATION BIO INC CLASS A | 2.1% |
|
ALUMIS INC | 2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | 2.1% |
|
TREVI THERAPEUTICS, INC. | 2.0% |
|
EDGEWISE THERAPEUTICS, INC. | 1.9% |
|
MAZE THERAPEUTICS INC | 1.7% |
XPH Underweight Relative to PJP
|
ABBOTT LABORATORIES | -5.2% |
|
ABBVIE INC | -5.1% |
|
AMGEN INC | -5.1% |
|
GILEAD SCIENCES INC | -4.7% |
|
ELI LILLY & CO | -3.6% |
|
TRAVERE THERAPEUTICS, INC. | -3.5% |
|
PFIZER INC | -3.5% |
|
JOHNSON & JOHNSON | -3.3% |
|
MERCK & CO. INC. | -3.1% |
|
BIOGEN IDEC INC | -2.9% |